Spinal Muscular Atrophy (SMA) Treatment Market: Global Industry Analysis and Forecast 2015 - 2021


Posted July 10, 2015 by veronicasavio

Persistence Market Research Pvt. Ltd is released new forthcoming report on title "Spinal Muscular Atrophy (SMA) Treatment Market: Global Industry Analysis and Forecast 2015 - 2021".

 
Spinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration. It typically results in weakness, and may even lead to death. SMA affects motor neurons present in the brain and spinal cord. These motor neurons are responsible for the transfer of electric and chemical signals to and from voluntary muscles in the body, enabling various physical activities such as walking, crawling, swallowing, and others.

Buy Full Report: http://www.persistencemarketresearch.com/market-research/spinal-muscular-atrophy-treatment-market.asp

SMA is caused due to genetic disorders (mutation or deletion). SMA can be characterized into type I, type II, type III, and type IV depending upon differences in cause and symptoms observed. The treatment of SMA involves gene replacement surgery or therapy; in addition, drugs may be administered to increase levels of survival motor neuron (SMN) protein. The SMA treatment market is growing at a significant rate due to the increasing prevalence of spinal muscular atrophy and rising awareness about diagnostics and treatment of SMA.

In addition, government initiatives and improving healthcare infrastructure are driving the market for SMA treatment. However, factors such as high costs involved in the treatment and lack of skilled professionals for surgical procedures and physiotherapy regimens restrain the market from growing.

North America dominates the global market for SMA treatment due to the high prevalence of SMA and increased adoption of SMA treatment options in the region. In addition, technological advancements in the field are driving the SMA treatment in the North America. Asia, followed by Europe, is expected to experience a high growth rate in the SMA treatment market in the next few years. China and India are expected to be the fastest-growing SMA treatment markets in the Asian region. Some of the key driving forces for the SMA treatment market in emerging countries are: A large pool of patients and rising government initiatives in the form of funding and strict laws. In addition, increasing awareness about the diagnosis and treatment of SMA is driving the market in the Asia region.

One of the major factors driving the global SMA treatment market is an increase in the prevalence of SMA. In addition, factors such as rising awareness, technological advancements, government initiatives, and improvement in the reimbursement scenario are driving the global SMA treatment market. However, the market will face impediments in the form of the high costs of treatment and lack of experienced professionals. In addition, a low adoption rate of SMA treatment options is restraining the market.

Growing population and economies in developing countries such as India and China are expected to offer sizeable opportunities for the global SMA treatment market. Innovation of more efficient products is expected to offer opportunities for the global SMA treatment market. A rising number of mergers and acquisitions, new product launches, and upsurge in collaborations and partnerships are some of the latest trends that have been observed in the global SMA treatment market.


Request Full TOC: http://www.persistencemarketresearch.com/toc/4759

Key points covered in the report
1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)
2) The report covers geographic segmentation
North America
Europe
Asia
RoW
3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
4) The report provides company profiles of some of the leading companies operating in the market
5) The report also provides porters five forces analysis of the market.-


About Us

Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact

Addie Thomas

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA - Canada Toll Free: 800-961-0353

Email: [email protected]

Web: http://www.persistencemarketresearch.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Addie Thomes
Phone 08009610353
Business Address Addie Thomas 305 Broadway 7th Floor, New York Cit
Country United States
Categories Business
Tags spinal muscular atrophy sm atreatment , spinal muscular atrophy sm atreatment market
Last Updated July 10, 2015